About Publications

Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.

Reports Index


  • Developing and Sustaining an Effective and Resilient Oncology Careforce: Proceedings of a Workshop Released: September 26, 2019
    In February 2019, the National Cancer Policy Forum convened a workshop to examine opportunities to better support the oncology careforce—the health care professionals and family caregivers caring for people with cancer.
  • Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors: Proceedings of a Workshop Released: July 12, 2019
    In recent years, significant progress has been made in the clinical development and use of immunotherapy for cancer treatment. Immune checkpoint inhibitors—one type of immunotherapy—have changed the standard of care for many different types cancer and spurred a great deal of new drug development activity.
  • Improving Cancer Diagnosis and Care Clinical Application of Computational Methods in Precision Oncology: Proceedings of a Workshop Released: June 20, 2019
    Precision oncology therapies, which target specific abnormalities in a patient’s cancer, are changing the nature of cancer treatment by enabling clinicians to select therapies that are most likely to benefit individual patients.
  • Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging and Pathology Expertise and Technologies: Proceedings of a Workshop Released: September 11, 2018
    To examine opportunities to improve cancer diagnosis and care, the National Cancer Policy Forum developed a two-workshop series. The first workshop—held on February 12-13, 2018 in Washington, DC—focused on potential strategies to ensure patients have access to appropriate expertise and technologies in oncologic pathology and imaging to inform cancer diagnosis and subsequent care decisions.
  • Establishing Effective Patient Navigation Programs in Oncology: Proceedings of a Workshop Released: May 24, 2018
    Delivering high-quality cancer care to all patients presents numerous challenges, including difficulties with ensuring patients have access to well-coordinated care across the cancer continuum. Patient navigation programs are designed to promote access to timely cancer diagnosis and care by addressing barriers to cancer care, such as challenges with health literacy, language barriers affecting comprehension of diagnosis and treatment, lack of transportation, or insufficient insurance coverage. Patient navigation programs were originally designed—and are still primarily directed at—improving cancer care among vulnerable patients.
  • Long-Term Survivorship Care After Cancer Treatment: Proceedings of a Workshop Released: April 27, 2018
    To examine progress in cancer survivorship care since the consensus report From Cancer Patient to Cancer Survivor: Lost in Transition, the National Cancer Policy Forum held a workshop, “Long-Term Survivorship Care After Cancer Treatment” on July 24 and July 25, 2017, in Washington, DC. Workshop presentations and discussions highlighted potential opportunities to improve the planning, management, and delivery of cancer survivorship care.
  • Incorporating Weight Management and Physical Activity Throughout the Cancer Care Continuum: Proceedings of a Workshop Released: December 01, 2017
    The National Cancer Policy Forum held a public workshop in February 2017 to examine the potential for weight management and physical activity interventions to improve health outcomes for cancer survivors. The workshop, Incorporating Weight Management and Physical Activity throughout the Cancer Care Continuum, highlighted the current evidence base, gaps in knowledge, and research needs on the associations among obesity, physical activity, weight management, and health outcomes for cancer survivors.
  • The Drug Development Paradigm in Oncology: Proceedings of a Workshop Released: July 24, 2017
    Advances in cancer research have led to an improved understanding of the molecular mechanisms underpinning the development of cancer and how the immune system responds to cancer. This influx of research has led to an increasing number and variety of cancer therapies in the drug development pipeline. Compared with standard chemotherapies, these new cancer therapies may demonstrate evidence of benefit at an earlier stage of development.
  • Cancer Care in Low-Resource Areas: Cancer Treatment, Palliative Care, and Survivorship Care: Proceedings of a Workshop Released: May 23, 2017
    Though cancer was once considered to be a problem primarily in wealthy nations, low- and middle-income countries now bear a majority share of the global cancer burden. Disparities in cancer outcomes also exist in high-income countries—communities within wealthier nations can experience worse cancer outcomes, especially if they have challenges in accessing cancer prevention and cancer care services.
  • Implementation of Lung Cancer Screening: Proceedings of a Workshop Released: November 17, 2016
    Lung cancer is the leading cause of cancer-related death in the United States; each year, more people die from lung cancer than from colon, breast, and prostate cancers combined. There has been a push to develop and implement screening strategies for the early detection of lung cancer. The National Lung Screening Trial evaluated the effectiveness of annual screening with low-dose computed tomography to reduce lung cancer mortality among individuals at high risk.